Resting Energy Expenditure
17
1
2
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (17)
Comparative Evaluation of smART+ REE Module to an FDA-cleared Device, for REE Calculation in ICU Patients
The Interaction Between Resting Metabolic Rate, Physical Activity and Thyroid Hormone in Females
MIrabegron and Physiological Function in Cold Environments
Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management
Mirabegron and Physiological Function in Cold Environments
Bionenergetic Balance During CVVH
Effects of Xanthohumol on Resting Energy Expenditure and Substrate Oxidation in Healthy Women
Indirect Calorimetry in Patients at Risk of Malnutrition
Influence of Ambient Temperature on Resting Energy Expenditure of Healthy Adults
Novel Equation for Estimating Resting Energy Expenditure in Dialysis Patients
The Relationship Between the Change of Resting Energy Expenditure and Nutritional Status .
Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
Novel Equation for Estimating Resting Energy Expenditure
Time Restricted Feeding in Male Runners
Predicting Resting Energy Expenditure in Critically Ill Patients by Measuring Lean Body Mass by US
Metabolic Effects of Differential Organ Growth Rates
Bach Music in Preterm Infants: No "Mozart Effect" on Resting Energy Expenditure